IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

Use an existing password
Company dossier

IOL Chemicals & Pharmaceuticals

NSE:IOLCP · ISIN INE485C01029

Close
Unavailable
Date unavailable
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
IOL Chemicals & Pharmaceuticals

Filings

Preserved evidence

Primary-source filing timeline

40 recent events
General Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Approval From NMPA, China For Clopidogrel Bisulfate APIBSE · exchange filing · pdf
Source filing
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Credit Rating - IOL Chemicals and Pharmaceuticals LimitedNSE · credit rating · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Credit RatingBSE · credit rating · pdf
Archived filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing
Trading Window - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
General Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Communication To Shareholders Relating To Unclaimed DividendBSE · corporate action · pdf
Source filing
General Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing
Disclosure under SEBI Takeover Regulations - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · conference call · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · conference call · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · conference call · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
Investor Presentation - IOL Chemicals and Pharmaceuticals LimitedNSE · investor presentation · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · financial results · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Fixed 39Th Annual General Meeting Of The Company And Book Closure Of Register Of MembersBSE · exchange filing · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2026BSE · financial results · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2026BSE · financial results · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Comments Of Board Of DirectorsBSE · exchange filing · pdf
Source filing
Outcome of Board Meeting - IOL Chemicals and Pharmaceuticals LimitedNSE · financial results · pdf
Source filing
Press Release - IOL Chemicals and Pharmaceuticals LimitedNSE · financial results · pdf
Source filing
General Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · conference call · pdf
Source filing
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Board Meeting Intimation for Notice Of The Board MeetingBSE · exchange filing · pdf
Source filing
Spurt in Volume - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing